Engineered α-Helical Peptides with Chelating Agents as Approach to Antibacterial Therapeutics

Area of Science:

• Biochemistry
• Structural Biology
• Antimicrobial Research

Background:

• Multidrug-resistant bacteria pose a significant global health threat.
• Developing novel antimicrobial agents with unique mechanisms of action is crucial.
• Alpha-helical antimicrobial peptides (α-HAMPs) show promise but require optimized design strategies.

Purpose of the Study:

• To design and synthesize a new class of α-helical antimicrobial peptides.
• To investigate the structure-activity relationship of these peptides using the main mechanical forces (MMFs) methodology.
• To evaluate the antimicrobial efficacy against various bacterial strains, including multidrug-resistant pathogens.

Main Methods:

• Structure-based design utilizing the main mechanical forces (MMFs) methodology for stable helical conformations.
• Rational design incorporating amphipathic properties with strategically positioned hydrophobic and cationic residues.
• Antimicrobial activity assays against Gram-positive and Gram-negative bacteria, including resistant strains.
• Evaluation of synergistic effects with the metal-chelating agent allomaltol.

Main Results:

• Designed peptides demonstrated significant antimicrobial activity against a broad spectrum of bacteria.
• The MMFs methodology accurately predicted peptide secondary structure, aligning with NMR data.
• Coadministration with allomaltol enhanced antimicrobial potency, indicating a dual mechanism of action.
• Covalent introduction of a chelating group improved potency by over 16-fold (MIC 18.75 μM vs. 300 μM).

Conclusions:

• The MMFs methodology is a reliable tool for rational peptide design and secondary structure prediction.
• The designed amphipathic α-helical peptides are effective against multidrug-resistant bacteria.
• Combining amphipathic helicity with metal-ion sequestration offers a synergistic and potent antimicrobial strategy.